Global and United States Antisense and RNAi Therapeutics Market Report & Forecast 2022-2028

Global and United States Antisense and RNAi Therapeutics Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Antisense and RNAi Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Antisense and RNAi Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Antisense and RNAi Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Antisense and RNAi Therapeutics Market Size for the Year 2017-2028
1.3 Antisense and RNAi Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Antisense and RNAi Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Antisense and RNAi Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Antisense and RNAi Therapeutics Market Dynamics
1.4.1 Antisense and RNAi Therapeutics Industry Trends
1.4.2 Antisense and RNAi Therapeutics Market Drivers
1.4.3 Antisense and RNAi Therapeutics Market Challenges
1.4.4 Antisense and RNAi Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Antisense and RNAi Therapeutics by Type
2.1 Antisense and RNAi Therapeutics Market Segment by Type
2.1.1 RNA Interference
2.1.2 Antisense RNA
2.2 Global Antisense and RNAi Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Antisense and RNAi Therapeutics Market Size by Type (2017-2028)
2.4 United States Antisense and RNAi Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Antisense and RNAi Therapeutics Market Size by Type (2017-2028)
3 Antisense and RNAi Therapeutics by Application
3.1 Antisense and RNAi Therapeutics Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.2 Global Antisense and RNAi Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Antisense and RNAi Therapeutics Market Size by Application (2017-2028)
3.4 United States Antisense and RNAi Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Antisense and RNAi Therapeutics Market Size by Application (2017-2028)
4 Global Antisense and RNAi Therapeutics Competitor Landscape by Company
4.1 Global Antisense and RNAi Therapeutics Market Size by Company
4.1.1 Top Global Antisense and RNAi Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Antisense and RNAi Therapeutics Revenue by Player (2017-2022)
4.2 Global Antisense and RNAi Therapeutics Concentration Ratio (CR)
4.2.1 Antisense and RNAi Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Antisense and RNAi Therapeutics in 2021
4.2.3 Global Antisense and RNAi Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Antisense and RNAi Therapeutics Headquarters, Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Antisense and RNAi Therapeutics Headquarters and Area Served
4.3.2 Global Antisense and RNAi Therapeutics Companies Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Antisense and RNAi Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Antisense and RNAi Therapeutics Market Size by Company
4.5.1 Top Antisense and RNAi Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Antisense and RNAi Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Antisense and RNAi Therapeutics Market Size by Region
5.1 Global Antisense and RNAi Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Antisense and RNAi Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Antisense and RNAi Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Antisense and RNAi Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Antisense and RNAi Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Antisense and RNAi Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Antisense and RNAi Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Antisense and RNAi Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Antisense and RNAi Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Antisense and RNAi Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Antisense and RNAi Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Antisense and RNAi Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Antisense and RNAi Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Antisense and RNAi Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Tekmira Pharmaceuticals
7.1.1 Tekmira Pharmaceuticals Company Details
7.1.2 Tekmira Pharmaceuticals Business Overview
7.1.3 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Introduction
7.1.4 Tekmira Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
7.1.5 Tekmira Pharmaceuticals Recent Development
7.2 Arbutus Biopharma
7.2.1 Arbutus Biopharma Company Details
7.2.2 Arbutus Biopharma Business Overview
7.2.3 Arbutus Biopharma Antisense and RNAi Therapeutics Introduction
7.2.4 Arbutus Biopharma Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
7.2.5 Arbutus Biopharma Recent Development
7.3 Alnylam Pharmaceuticals
7.3.1 Alnylam Pharmaceuticals Company Details
7.3.2 Alnylam Pharmaceuticals Business Overview
7.3.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Introduction
7.3.4 Alnylam Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
7.3.5 Alnylam Pharmaceuticals Recent Development
7.4 Antisense Therapeutics
7.4.1 Antisense Therapeutics Company Details
7.4.2 Antisense Therapeutics Business Overview
7.4.3 Antisense Therapeutics Antisense and RNAi Therapeutics Introduction
7.4.4 Antisense Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
7.4.5 Antisense Therapeutics Recent Development
7.5 Silence Therapeutics
7.5.1 Silence Therapeutics Company Details
7.5.2 Silence Therapeutics Business Overview
7.5.3 Silence Therapeutics Antisense and RNAi Therapeutics Introduction
7.5.4 Silence Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
7.5.5 Silence Therapeutics Recent Development
7.6 Isis Pharmaceuticals
7.6.1 Isis Pharmaceuticals Company Details
7.6.2 Isis Pharmaceuticals Business Overview
7.6.3 Isis Pharmaceuticals Antisense and RNAi Therapeutics Introduction
7.6.4 Isis Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
7.6.5 Isis Pharmaceuticals Recent Development
7.7 Sirnaomics
7.7.1 Sirnaomics Company Details
7.7.2 Sirnaomics Business Overview
7.7.3 Sirnaomics Antisense and RNAi Therapeutics Introduction
7.7.4 Sirnaomics Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
7.7.5 Sirnaomics Recent Development
7.8 Santaris
7.8.1 Santaris Company Details
7.8.2 Santaris Business Overview
7.8.3 Santaris Antisense and RNAi Therapeutics Introduction
7.8.4 Santaris Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
7.8.5 Santaris Recent Development
7.9 Roche
7.9.1 Roche Company Details
7.9.2 Roche Business Overview
7.9.3 Roche Antisense and RNAi Therapeutics Introduction
7.9.4 Roche Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
7.9.5 Roche Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Antisense and RNAi Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Antisense and RNAi Therapeutics Market Trends
Table 3. Antisense and RNAi Therapeutics Market Drivers
Table 4. Antisense and RNAi Therapeutics Market Challenges
Table 5. Antisense and RNAi Therapeutics Market Restraints
Table 6. Global Antisense and RNAi Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Antisense and RNAi Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Antisense and RNAi Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Antisense and RNAi Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Antisense and RNAi Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Antisense and RNAi Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Antisense and RNAi Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Antisense and RNAi Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antisense and RNAi Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense and RNAi Therapeutics as of 2021)
Table 15. Top Players of Antisense and RNAi Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Antisense and RNAi Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Antisense and RNAi Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Antisense and RNAi Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Antisense and RNAi Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Antisense and RNAi Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Antisense and RNAi Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Antisense and RNAi Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Antisense and RNAi Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Antisense and RNAi Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Antisense and RNAi Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Antisense and RNAi Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Antisense and RNAi Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Tekmira Pharmaceuticals Company Details
Table 31. Tekmira Pharmaceuticals Business Overview
Table 32. Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 33. Tekmira Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 34. Tekmira Pharmaceuticals Recent Development
Table 35. Arbutus Biopharma Company Details
Table 36. Arbutus Biopharma Business Overview
Table 37. Arbutus Biopharma Antisense and RNAi Therapeutics Product
Table 38. Arbutus Biopharma Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 39. Arbutus Biopharma Recent Development
Table 40. Alnylam Pharmaceuticals Company Details
Table 41. Alnylam Pharmaceuticals Business Overview
Table 42. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 43. Alnylam Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 44. Alnylam Pharmaceuticals Recent Development
Table 45. Antisense Therapeutics Company Details
Table 46. Antisense Therapeutics Business Overview
Table 47. Antisense Therapeutics Antisense and RNAi Therapeutics Product
Table 48. Antisense Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 49. Antisense Therapeutics Recent Development
Table 50. Silence Therapeutics Company Details
Table 51. Silence Therapeutics Business Overview
Table 52. Silence Therapeutics Antisense and RNAi Therapeutics Product
Table 53. Silence Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Silence Therapeutics Recent Development
Table 55. Isis Pharmaceuticals Company Details
Table 56. Isis Pharmaceuticals Business Overview
Table 57. Isis Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 58. Isis Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 59. Isis Pharmaceuticals Recent Development
Table 60. Sirnaomics Company Details
Table 61. Sirnaomics Business Overview
Table 62. Sirnaomics Antisense and RNAi Therapeutics Product
Table 63. Sirnaomics Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 64. Sirnaomics Recent Development
Table 65. Santaris Company Details
Table 66. Santaris Business Overview
Table 67. Santaris Antisense and RNAi Therapeutics Product
Table 68. Santaris Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Santaris Recent Development
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche Antisense and RNAi Therapeutics Product
Table 73. Roche Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 74. Roche Recent Development
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
List of Figures
Figure 1. Antisense and RNAi Therapeutics Product Picture
Figure 2. Global Antisense and RNAi Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Antisense and RNAi Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Antisense and RNAi Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Antisense and RNAi Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Antisense and RNAi Therapeutics Market Share in Global 2017-2028
Figure 7. Antisense and RNAi Therapeutics Report Years Considered
Figure 8. Product Picture of RNA Interference
Figure 9. Product Picture of Antisense RNA
Figure 10. Global Antisense and RNAi Therapeutics Market Share by Type in 2022 & 2028
Figure 11. Global Antisense and RNAi Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Antisense and RNAi Therapeutics Market Share by Type (2017-2028)
Figure 13. United States Antisense and RNAi Therapeutics Market Share by Type in 2022 & 2028
Figure 14. United States Antisense and RNAi Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Antisense and RNAi Therapeutics Market Share by Type (2017-2028)
Figure 16. Product Picture of Hospital
Figure 17. Product Picture of Clinic
Figure 18. Global Antisense and RNAi Therapeutics Market Share by Application in 2022 & 2028
Figure 19. Global Antisense and RNAi Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 20. Global Antisense and RNAi Therapeutics Market Share by Application (2017-2028)
Figure 21. United States Antisense and RNAi Therapeutics Market Share by Application in 2022 & 2028
Figure 22. United States Antisense and RNAi Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 23. United States Antisense and RNAi Therapeutics Market Share by Application (2017-2028)
Figure 24. North America Antisense and RNAi Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 25. U.S. Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 26. Canada Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Europe Antisense and RNAi Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. Germany Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. France Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. U.K. Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Italy Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Russia Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Antisense and RNAi Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 34. China Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Japan Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. South Korea Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. India Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Australia Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Taiwan Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Indonesia Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Thailand Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Malaysia Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Philippines Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Latin America Antisense and RNAi Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 45. Mexico Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Brazil Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Argentina Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Antisense and RNAi Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Turkey Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Saudi Arabia Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. UAE Antisense and RNAi Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Tekmira Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 53. Arbutus Biopharma Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 54. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 55. Antisense Therapeutics Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 56. Silence Therapeutics Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 57. Isis Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 58. Sirnaomics Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 59. Santaris Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 60. Roche Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Targeted RNA Sequencing Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 71

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing The ability to detect both known and novel gene fusion partners in many sample types. In The report, we ......

Global Targeted RNA Sequencing Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87

According to our LPI (LP Information) latest study, the global Targeted RNA Sequencing market size was valued at US$ 1761.4 million in 2023. With growing demand in downstream market, the Targeted RNA Sequencing is forecast to a readjusted size of US$ 7649.2 million by 2030 with a CAGR of 23.3% during review period. The research report highlights the growth potential of the global Targeted RNA Sequencing market. Targeted RNA Sequencing are expected to show stable growth in the future mark......

Global Targeted RNA Sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 94

According to our (Global Info Research) latest study, the global Targeted RNA Sequencing market size was valued at USD 1852.7 million in 2023 and is forecast to a readjusted size of USD 7255.4 million by 2030 with a CAGR of 21.5% during review period. Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or ......

Global Antisense and RNAi Therapeutics Market Research Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 133

Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......

Global Antisense and RNAi Therapeutics Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101

Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......

Global Targeted RNA Sequencing Market Research Report 2023, Forecast to 2028

Published: 13-Nov-2023        Price: US 2680 Onwards        Pages: 137

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......

Global Targeted RNA Sequencing Professional Survey Report 2023, Forecast to 2028

Published: 13-Nov-2023        Price: US 3280 Onwards        Pages: 100

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......

Global RNAi for Therapeutic Market Status and Outlook 2023-2028

Published: 08-Nov-2023        Price: US 3160 Onwards        Pages: 106

RNAi is a fundamental cellular mechanism for silencing gene expression that can be harnessed for the development of new drugs Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......

Global RNAi for Therapeutic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 104

Market Overview of Global RNAi for Therapeutic market: According to our latest research, the global RNAi for Therapeutic market looks promising in the next 5 years. As of 2022, the global RNAi for Therapeutic market was estimated at USD 260.55 million, and it's anticipated to reach USD 3633.33 million in 2028, with a CAGR of 55.14% during the forecast years. RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs